Alterity Therapeutics Ltd (ATHE)
1.961
0.00 (0.00%)
USD |
NASDAQ |
May 21, 16:00
1.92
-0.04
(-2.10%)
After-Hours: 20:00
Alterity Therapeutics Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 21, 2024 | 6.680M |
| May 20, 2024 | 6.670M |
| May 17, 2024 | 7.019M |
| May 16, 2024 | 7.194M |
| May 15, 2024 | 7.368M |
| May 14, 2024 | 7.893M |
| May 13, 2024 | 7.63M |
| May 10, 2024 | 7.106M |
| May 09, 2024 | 7.019M |
| May 08, 2024 | 7.368M |
| May 07, 2024 | 7.892M |
| May 06, 2024 | 7.106M |
| May 03, 2024 | 7.455M |
| May 02, 2024 | 8.241M |
| May 01, 2024 | 8.765M |
| April 30, 2024 | 7.848M |
| April 29, 2024 | 8.721M |
| April 26, 2024 | 11.47M |
| April 25, 2024 | 9.289M |
| April 24, 2024 | 9.900M |
| April 23, 2024 | 8.154M |
| April 22, 2024 | 8.154M |
| April 19, 2024 | 7.368M |
| April 18, 2024 | 8.241M |
| April 17, 2024 | 7.106M |
| Date | Value |
|---|---|
| April 16, 2024 | 7.455M |
| April 15, 2024 | 10.95M |
| April 12, 2024 | 15.23M |
| April 11, 2024 | 12.52M |
| April 10, 2024 | 8.678M |
| April 09, 2024 | 6.233M |
| April 08, 2024 | 5.971M |
| April 05, 2024 | 5.971M |
| April 04, 2024 | 5.578M |
| April 03, 2024 | 5.622M |
| April 02, 2024 | 5.535M |
| April 01, 2024 | 6.582M |
| March 28, 2024 | 7.63M |
| March 27, 2024 | 7.194M |
| March 26, 2024 | 5.273M |
| March 25, 2024 | 4.487M |
| March 22, 2024 | 5.011M |
| March 21, 2024 | 5.011M |
| March 20, 2024 | 4.487M |
| March 19, 2024 | 4.138M |
| March 18, 2024 | 5.273M |
| March 15, 2024 | 4.924M |
| March 14, 2024 | 5.273M |
| March 13, 2024 | 5.884M |
| March 12, 2024 | 4.051M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-12.11M
Minimum
Dec 28 2022
59.91M
Maximum
Jul 08 2021
9.343M
Average
4.106M
Median
Nov 26 2019
Enterprise Value Benchmarks
| Kazia Therapeutics Ltd | 5.246M |
| Immutep Ltd | -- |
| Opthea Ltd | 123.80M |
| Mesoblast Ltd | -- |
| Immuron Ltd | 2.087M |